NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$29,138
-1.89%
Shares
Shares Volume: 16,650 Shares
Average Share Price: $1.75
INSIDER
ROBIN HOWARD W
President & CEO (Director)
reported on May 20 2024
traded on May 17 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 863,649 |
PURCHASES/SALES 1Y | 0 / 4 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $17,024.53 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
PURCHASES/SALES 1Y | 0 / 17 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $14,958.84 |
COMPANY PREVIOUS TRADES |